Retinal vasculitis in rheumatoid arthritis.
نویسندگان
چکیده
منابع مشابه
Retinal vasculitis in rheumatoid arthritis.
A woman with exacerbation of severe rheumatoid arthritis developed lesions compatible with retinal vasculitis. Laboratory studies confirmed the diagnosis, and the rapid clinical improvement that accompanied a fall in circulating immune complexes suggested that the vasculitis was a direct consequence of the rheumatoid disease. From these observations retinal vasculitis should probably be sought ...
متن کاملIsolated nail fold vasculitis in rheumatoid arthritis.
OBJECTIVES To establish the clinical significance of isolated nail fold vasculitis in patients with rheumatoid arthritis (RA). METHODS Patients attending hospital with established RA were assessed by a single observer using unaided vision. Isolated nail fold vasculitis (NFV) was diagnosed as small nail edge or nail fold lesions without any evidence of other extra-articular or systemic vasculi...
متن کاملCan rheumatoid vasculitis predate a diagnosis of rheumatoid arthritis?
We report regarding a male patient who presented with a systemic vasculitis that was consistent with a diagnosis of polyarteritis nodosa. At presentation, he had no features of inflammatory arthritis but had a high rheumatoid factor titer and low C4 level. Withdrawal of immunosuppression after 6 years resulted in the development of classical rheumatoid arthritis (RA). This case supports previou...
متن کاملComparing bone mineral density in rheumatoid arthritis and psoriatic arthritis
Background: Changes in patients’ bone mineral density (BMD) is one of the problems in patients with rheumatoid arthritis, which can be due to the use of corticosteroid drugs to reduce patients' symptoms or due to the aging process in patients. In this study, we decided to compare BMD in patients with psoriatic arthritis and rheumatoid arthritis. Methods: This study as a cross-sectional descrip...
متن کاملTocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.
SIR, Biologic agents are widely used for the treatment of RA in today’s treat-to-target era [1]. Although their safety and efficacy are acceptable, autoimmune adverse events associated with biologics have increasingly been reported. According to the BIOGEAS Study Group [2], vasculitis and SLE are the most frequent autoimmune diseases induced by biologics, and most reports were associated with a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1981
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.282.6278.1745